MENU
Advertisement
June 12, 2026
Spectrum Vascular Acquires Piccolo Medical
June 12, 2026—Spectrum Vascular announced the acquisition of Piccolo Medical, a developer of catheter guidance products.
Read Article
News | June 12, 2026Jun122026
Medtronic Completes Acquisition of Scientia Vascular
June 12, 2026—Medtronic announced it has completed its acquisition of Scientia Vascular, a privately held developer of access products for the treatment of complex neurovascular conditions.
WaveClear Licenses Resolution Thrombectomy Technology to Two Chinese Companies
June 12, 2026—WaveClear Vascular, developer of the Resolution cavitation system, announced that it has entered into licensing agreements with two Chinese medical device companies for Resolution, a 6-F catheter-based thrombectomy platform for the treatment of peripheral vascular disease.
News | June 11, 2026Jun112026
Penumbra’s Thunderbolt CAVT Platform Cleared by FDA for Stroke Treatment
June 11, 2026—Penumbra, Inc. announced it has received FDA clearance for the Thunderbolt computer-assisted vacuum thrombectomy (CAVT) platform for the treatment of acute ischemic stroke.
Ventiv Scientific’s V-Pulse Mechanical Thrombectomy System Used in FIH Procedures
June 11, 2026—Ventiv Scientific announced the completion of the first-in-human (FIH) clinical procedures with its V-Pulse mechanical thrombectomy system.
News | June 10, 2026Jun102026
Complete Adherence to Guideline-Directed Care in PAD Shows Decreased MALE at 2 Years
June 10, 2026—The Society for Vascular Surgery (SVS) announced that new study data show that patients with peripheral artery disease who adhere to preoperative guideline-directed care (GDC) are more likely to remain free from major adverse limb events (MALE) for up to 2 years after intervention.
News | June 9, 2026Jun092026
FDA Approves CyndRx’s AbsorbaSeal Vascular Closure Device
June 9, 2026—CyndRx, LLC, announced FDA approval of its AbsorbaSeal vascular closure device.
Gore Viabahn Fortegra Venous Stent Receives CE Mark Approval Under EU MDR
June 9, 2026—Gore & Associates announced CE Mark approval for its Viabahn Fortegra venous stent, indicated for use in the treatment of symptomatic inferior vena cava (IVC) and iliofemoral venous outflow obstruction. The approval is granted under the European Union Medical Device Regulation.
CLTI: Evidence, Tools, & Tactics
Clinical trial updates and nuanced approaches to complex limb preservation scenarios.
View Issue
May 5, 2026
Solaris DE Drug-Eluting Covered Stent Receives FDA Breakthrough Device Designation
February 9, 2026
DISTALS Results Presented for Rapid Medical Tigertriever 13 in MVO Stroke
April 13, 2026
Stryker to Acquire Amplitude Vascular Systems